Bausch + Lomb
BLCO · NYSE
Bulios Fair Price
$14.54
15.0% downside
Current Price
$17.1
According to Bulios Fair Price, BLCO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Bausch + Lomb Corporation is a Canadian global company specializing in the development, manufacturing, and marketing of healthcare products, particularly in the field of ophthalmology and eye care. The company offers a wide range of products, including contact lenses, eye drops, surgical instruments for eye surgeries, and medications for treating various eye conditions. Bausch + Lomb also focuses on the development of advanced eye technologies and providing comprehensive vision care for patients worldwide. The company is known for its long-standing tradition and expertise in eye medicine.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Brenton L. Saunders
Employees
13,000
Headquarters
Vaughan
Upcoming events
Earnings
Upcoming earnings report